Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei 230001, PR China.
The First Clinical Medical College of Lanzhou University, Lanzhou 730000, PR China; Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, The First Hospital of Lanzhou University, Lanzhou 730000, PR China.
Biomed Pharmacother. 2023 Oct;166:115390. doi: 10.1016/j.biopha.2023.115390. Epub 2023 Sep 4.
The tumor microenvironment (TME) is crucial in cancer progression, and the extracellular matrix (ECM) is an important TME component. Collagen is a major ECM component that contributes to tumor cell infiltration, expansion, and distant metastasis during cancer progression. Recent studies reported that collagen is deposited in the TME to form a collagen wall along which tumor cells can infiltrate and prevent drugs from working on the tumor cells. Collagen-tumor cell interaction is complex and requires the activation of multiple signaling pathways for biochemical and mechanical signaling interventions. In this review, we examine the effect of collagen deposition in the TME on tumor progression and discuss the interaction between collagen and tumor cells. This review aims to illustrate the functions and mechanisms of collagen in tumor progression in the TME and its role in tumor therapy. The findings indicated collagen in the TME appears to be a better target for cancer therapy.
肿瘤微环境(TME)在癌症进展中至关重要,细胞外基质(ECM)是 TME 的重要组成部分。胶原是 ECM 的主要成分之一,它在癌症进展过程中有助于肿瘤细胞浸润、扩张和远处转移。最近的研究报告称,胶原在 TME 中沉积,形成胶原壁,肿瘤细胞可以沿着该壁浸润,并阻止药物作用于肿瘤细胞。胶原-肿瘤细胞相互作用复杂,需要激活多个信号通路,以进行生化和机械信号干预。在这篇综述中,我们研究了 TME 中胶原沉积对肿瘤进展的影响,并讨论了胶原与肿瘤细胞的相互作用。本综述旨在阐明胶原在 TME 中对肿瘤进展的功能和机制及其在肿瘤治疗中的作用。研究结果表明,TME 中的胶原似乎是癌症治疗的更好靶点。
Biomed Pharmacother. 2023-10
Acta Biomater. 2021-8
Biomaterials. 2018-2-13
Biochem Soc Trans. 2024-6-26
Adv Exp Med Biol. 2020
J Cancer Res Ther. 2021
Cancer Res. 2021-11-15
Mol Cancer. 2021-12-1
Exp Hematol Oncol. 2025-7-29
J Hematol Oncol. 2025-6-19
Nat Commun. 2025-6-5